Premium
Targeted therapy in endometrial cancer: Making progress
Author(s) -
Mutch David G.
Publication year - 2016
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.30285
Subject(s) - medicine , targeted therapy , endometrial cancer , cancer , oncology , chemotherapy , disease
The most promising avenue for treating cancers that progress after standard chemotherapy regimens is targeted therapy, in which drugs are chosen to disrupt specific pathways known to be important in disease progression. Significant progress is being made in targeted therapies as we gain understanding of the molecular basis of the cancers we treat. See also pages 3519–28.